{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T09:27:37Z","timestamp":1792056457626,"version":"4.4.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1097\/mbc.0000000000000296","type":"journal-article","created":{"date-parts":[[2015,4,3]],"date-time":"2015-04-03T17:46:18Z","timestamp":1428083178000},"page":"555-559","source":"Crossref","is-referenced-by-count":25,"title":["Effect of serum monoclonal protein concentration on haemostasis in patients with multiple myeloma"],"prefix":"10.1097","volume":"26","author":[{"given":"Heyu","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dengju","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210203","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1055\/s-0031-1297372","article-title":"Bleeding and thrombosis in multiple myeloma and related plasma cell disorders.","volume":"37","author":"Coppola","year":"2011","journal-title":"Semin Thromb Hemost"},{"key":"R2-12-20210203","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1365-2141.2008.07577.x","article-title":"Pathogenesis and management of bleeding and thrombosis in plasma cell dyscrasias.","volume":"145","author":"Eby","year":"2009","journal-title":"Br J Haematol"},{"key":"R4-12-20210203","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000160182","article-title":"Acquired dysfibrinogenemia secondary to multiple myeloma.","volume":"120","author":"Kotlin","year":"2008","journal-title":"Acta Haematol"},{"key":"R5-12-20210203","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/ijlh.12036","article-title":"Prolonged prothrombin time correlates with serum monoclonal protein concentration in patients with plasma cell dyscrasia.","volume":"35","author":"Pandey","year":"2013","journal-title":"Int J Lab Hematol"},{"key":"R6-12-20210203","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1160\/TH10-03-0187","article-title":"Microparticle-associated tissue factor activity and venous thrombosis in multiple myeloma.","volume":"105","author":"Auwerda","year":"2011","journal-title":"Thromb Haemost"},{"key":"R7-12-20210203","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4065\/78.1.21","article-title":"Review of 1027 patients with newly diagnosed multiple myeloma.","volume":"78","author":"Kyle","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"R8-12-20210203","doi-asserted-by":"crossref","first-page":"462","DOI":"10.3816\/CLM.2007.n.027","article-title":"Prothrombotic coagulation abnormalities in patients with paraprotein-producing B-cell disorders.","volume":"7","author":"Auwerda","year":"2007","journal-title":"Clin Lymphoma Myeloma"},{"key":"R9-12-20210203","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1007\/s12032-012-0290-0","article-title":"Hemostatic changes after 1 month of thalidomide and dexamethasone therapy in patients with multiple myeloma.","volume":"29","author":"Robak","year":"2012","journal-title":"Med Oncol"},{"key":"R10-12-20210203","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/jjco\/hym074","article-title":"The prolonged activated partial thromboplastin time at diagnosis indicates less favorable prognosis in IgA myeloma.","volume":"37","author":"Teng","year":"2007","journal-title":"Jpn J Clin Oncol"},{"key":"R11-12-20210203","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.leukres.2007.12.002","article-title":"Prospective evaluation of coagulopathy in multiple myeloma patients before, during and after various chemotherapeutic regimens.","volume":"32","author":"van Marion","year":"2008","journal-title":"Leuk Res"},{"key":"R12-12-20210203","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.thromres.2003.12.007","article-title":"Disturbances of anticoagulation and fibrinolytic systems in monoclonal gammopathies-another mechanism of M-protein interference with hemostasis.","volume":"112","author":"Spicka","year":"2003","journal-title":"Thromb Res"},{"key":"R13-12-20210203","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1038\/leu.2012.43","article-title":"Absence of tissue factor expression by neoplastic plasma cells in multiple myeloma.","volume":"26","author":"Cesarman-Maus","year":"2012","journal-title":"Leukemia"},{"key":"R14-12-20210203","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0049-3848(02)00003-8","article-title":"Oxidative stress and platelet function in multiple myeloma and renal insufficiency: clinical relations of different tests.","volume":"105","author":"Cieslar","year":"2002","journal-title":"Thromb Res"},{"key":"R15-12-20210203","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1160\/TH04-03-0193","article-title":"Characterization of a myeloma patient with a life-threatening hemorrhagic diathesis: presence of a lambda dimer protein inhibiting shear-induced platelet aggregation by binding to the A1 domain of von Willebrand factor.","volume":"93","author":"Shinagawa","year":"2005","journal-title":"Thromb Haemost"},{"key":"R16-12-20210203","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3960\/jslrt.50.71","article-title":"IgG type multiple myeloma and concurrent IgA type monoclonal gammopathy of undetermined significance complicated by necrotizing skin ulcers due to type I cryoglobulinemia.","volume":"50","author":"Ninomiya","year":"2010","journal-title":"J Clin Exp Hematop"},{"key":"R17-12-20210203","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/ajh.10449","article-title":"A nonimmunological phospholipid-dependent coagulation inhibitor associated with IgGlambda-type multiple myeloma.","volume":"75","author":"Takamiya","year":"2004","journal-title":"Am J Hematol"},{"key":"R18-12-20210203","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1055\/s-2007-976169","article-title":"Hemostatic dysfunction in paraproteinemias and amyloidosis.","volume":"33","author":"Zangari","year":"2007","journal-title":"Semin Thromb Hemost"},{"key":"R19-12-20210203","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1089\/152581601753193869","article-title":"Bleeding diathesis in multiple myeloma.","volume":"10","author":"Saif","year":"2001","journal-title":"J Hematother Stem Cell Res"},{"key":"R20-12-20210203","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000292899","article-title":"Multiple myeloma with monoclonal free IgG3 heavy chains and free kappa light chains.","volume":"123","author":"Richter","year":"2010","journal-title":"Acta Haematol"},{"key":"R21-12-20210203","first-page":"388","article-title":"Hemostatic complications associated with paraproteinemias.","volume":"2","author":"Eby","year":"2003","journal-title":"Curr Hematol Rep"}],"container-title":["Blood Coagulation &amp; Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MBC.0000000000000296","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:23:21Z","timestamp":1620959001000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001721-201507000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0000000000000296","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]}}}